In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Total investment management fees | | | | | 437.0 | 331.1 | | |
Open-end funds | 335.6 | 395.2 | 250.0 | 229.6 | 231.2 | 175.3 | | |
Institutional accounts | 157.4 | 148.2 | 113.5 | 96.4 | 77.7 | 46.6 | | |
Retail separate accounts | 171.5 | 174.9 | 104.9 | 83.0 | 73.5 | 54.3 | | |
Other | 221.9 | 261.0 | 135.4 | 154.2 | | | | |
Total revenues [+] | 886.4 | 979.2 | 603.9 | 563.2 | 552.2 | 425.6 | 458.2 | 382.0 |
Investment advisory | | | | | | | | 264.9 |
Revenue growth [+] | -9.5% | 62.2% | 7.2% | 2.0% | 29.8% | -7.1% | 20.0% | -15.2% |
Total investment management fees | | | | | 32.0% | | | |
Open-end funds | -15.1% | 58.0% | 8.9% | -0.7% | 31.9% | | | |
Institutional accounts | 6.2% | 30.5% | 17.7% | 24.1% | 66.8% | | | |
Retail separate accounts | -1.9% | 66.7% | 26.4% | 12.9% | 35.5% | | | |
Administration and shareholder service fees | | | | | 29.8% | | | |
Cost of goods sold | 371.3 | 358.2 | 267.3 | 240.5 | 238.5 | 191.4 | 135.6 | 137.1 |
Gross profit | 515.1 | 621.0 | 336.6 | 322.7 | 313.7 | 234.2 | 322.6 | 244.9 |
Gross margin | 58.1% | 63.4% | 55.7% | 57.3% | 56.8% | 55.0% | 70.4% | 64.1% |
Selling, general and administrative | 688.9 | 653.7 | 460.7 | 438.5 | 439.1 | 367.6 | 271.7 | 301.6 |
Other operating expenses | -437.7 | -406.6 | -303.2 | -278.1 | -268.3 | -217.6 | -9.8 | -143.8 |
EBITDA [+] | 265.7 | 376.3 | 183.2 | 166.7 | 146.6 | 86.9 | 60.9 | 87.3 |
EBITDA growth | -29.4% | 105.4% | 9.9% | 13.7% | 68.6% | 42.8% | -30.3% | -36.6% |
EBITDA margin | 30.0% | 38.4% | 30.3% | 29.6% | 26.5% | 20.4% | 13.3% | 22.9% |
Depreciation | 5.7 | 6.3 | 8.7 | 9.4 | 8.3 | 6.2 | 3.3 | 3.7 |
EBITA | 260.0 | 370.0 | 174.4 | 157.3 | 138.3 | 80.8 | 57.5 | 83.7 |
EBITA margin | 29.3% | 37.8% | 28.9% | 27.9% | 25.0% | 19.0% | 12.6% | 21.9% |
Amortization of intangibles | 58.5 | 44.5 | 30.1 | 30.2 | 25.1 | 12.2 | 2.5 | 3.3 |
EBIT [+] | 201.5 | 325.5 | 144.3 | 127.0 | 113.2 | 68.6 | 55.1 | 80.4 |
EBIT growth | -38.1% | 125.5% | 13.6% | 12.2% | 65.0% | 24.6% | -31.5% | -38.6% |
EBIT margin | 22.7% | 33.2% | 23.9% | 22.6% | 20.5% | 16.1% | 12.0% | 21.0% |
Non-recurring items [+] | 4.0 | | 1.2 | 2.3 | 0.1 | 10.6 | 4.3 | |
Restructuring charges | 4.0 | | 1.2 | 2.3 | 0.1 | 10.6 | 4.3 | |
Interest income | 18.4 | 21.8 | 13.7 | 7.7 | 19.1 | 4.2 | 10.2 | 13.9 |
Interest income | 18.4 | 21.8 | 13.7 | 7.7 | 19.1 | 4.2 | 10.2 | 13.9 |
Other income (expense), net [+] | -51.9 | 6.4 | 7.1 | 8.3 | -23.2 | 18.2 | 8.8 | -26.7 |
Change in value of contingent liability | 8.0 | 12.4 | | | | | | |
Other | -0.2 | 4.2 | 1.9 | 2.4 | 3.3 | 1.6 | 1.1 | 0.9 |
Pre-tax income | 163.9 | 353.7 | 163.9 | 140.7 | 109.0 | 80.4 | 69.8 | 67.6 |
Income taxes | 57.3 | 90.8 | 43.9 | 35.2 | 33.0 | 40.5 | 21.0 | 37.0 |
Tax rate | 34.9% | 25.7% | 26.8% | 25.0% | 30.2% | 50.3% | 30.1% | 54.7% |
Minority interest | 10.9 | -54.7 | -40.0 | 9.9 | | | | |
Net income | 117.5 | 208.1 | 80.0 | 87.3 | 67.2 | 28.7 | 48.5 | 35.1 |
Net margin | 13.3% | 21.3% | 13.2% | 15.5% | 12.2% | 6.7% | 10.6% | 9.2% |
|
Basic EPS [+] | $15.90 | $27.13 | $10.49 | $12.54 | $9.37 | $4.09 | $6.34 | $3.99 |
Growth | -41.4% | 158.5% | -16.3% | 33.9% | 129.1% | -35.5% | 58.9% | -62.9% |
Diluted EPS [+] | $15.50 | $26.01 | $10.02 | $10.71 | $7.88 | $3.96 | $6.20 | $3.92 |
Growth | -40.4% | 159.4% | -6.4% | 36.0% | 99.1% | -36.2% | 58.3% | -62.7% |
|
Dividends per share [+] | $6.30 | $4.64 | $2.98 | $2.44 | $2.00 | $1.80 | $1.80 | $1.80 |
Growth | 35.8% | 55.7% | 22.1% | 22.0% | 11.1% | 0.0% | 0.0% | 33.3% |
|
Shares outstanding (basic) [+] | 7.4 | 7.7 | 7.6 | 7.0 | 7.2 | 7.0 | 7.6 | 8.8 |
Growth | -3.7% | 0.7% | 9.4% | -2.9% | 2.3% | -8.3% | -13.1% | -3.2% |
Shares outstanding (diluted) [+] | 7.6 | 8.0 | 8.0 | 8.1 | 8.5 | 7.2 | 7.8 | 9.0 |
Growth | -5.3% | 0.3% | -2.1% | -4.4% | 17.7% | -7.4% | -12.7% | -3.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |